Suberoyl bis-hydroxamic acid
Suberoyl bis-hydroxamic acid (SBHA) is a histone deacetylase (HDAC) inhibitor used in research to study epigenetic regulation. It is applied in both in vitro and in vivo models to investigate gene expression, cell cycle, differentiation, and potential therapeutic strategies in oncology and neurology.
Product Specifications
CAS Number
38937-66-5
Product Name Alternative
Thyroid, SBHA, Suberoyl bis hydroxamic acid, Suberoyl bishydroxamic acid, Suberoyl bis-hydroxamic acid, Suberohydroxamic acid, Inhibitor, HDAC, HDAC3, HDAC1, Histone deacetylases, Malignant, Medullary, inhibit, MTC, neuroendocrine malignancy, mesothelioma, neoplastic disease, neoplasia, Apoptosis, carcinoma
Field of Research
Cell Biology, Epigenetics & Chromatin, Molecular Biology
Purity
99.88% (May vary between batches)
Solubility
DMSO:49 mg/mL (239.94 mM) ; H2O:8.16 mg/mL (39.96 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (9.79 mM)
Smiles
C (CCCCCCC (NO) =O) (NO) =O
Molecular Formula
C8H16N2O4
Molecular Weight
204.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP4955-01 10 µg
Recombinant Human Natural Killer Cell Receptor 2B4/SLAMF4/CD244 Protein (C-6His)
Sign In for Pricing
View Details